Opus Point Partners Management, LLC
Q3 2019 13F Holdings
- Locationnew york, NY
- Num holdings
55
- Value ($000)
$55,338
- Date Filed11/14/2019
- Form type13F-HR
- CIK0001600175
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2019 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ISHARES TR | NASDAQ BIOTECH | 464287556 | $12.44M | 23 % | 125,000 | ||
ISHARES TR | NASDAQ BIOTECH | 464287556 | $8.46M | 15 % | 85,000 | call | |
DIREXION SHS ETF TR | SP BIOTCH BL NEW | 25490K323 | $3.09M | 6 % | 99,855 | ||
METTLER TOLEDO INTERNATIONAL | COM | 592688105 | $2.28M | 4 % | 3,235 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | $1.67M | 3 % | 33,000 | ||
SEATTLE GENETICS INC | COM | 812578102 | $1.54M | 3 % | 18,020 | ||
ILLUMINA INC | COM | 452327109 | $1.44M | 3 % | 4,721 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | $1.4M | 3 % | 8,279 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | $1.21M | 2 % | 20,124 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | $1.1M | 2 % | 13,684 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100